Evidence map›Paper›PMID 38969762›Full record

ArticleNature cell biology2024

An activity-specificity trade-off encoded in human transcription factors.

Julian Naderi, Alexandre P Magalhaes, Gözde Kibar, Gregoire Stik, Yaotian Zhang, Sebastian D Mackowiak, Hannah M Wieler, Francesca Rossi, Rene Buschow, Marie Christou-Kent and 4 more

Abstract read
In one paragraph

Article in Nature cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Enhanced Activities of OCT4 and SOX2 Promote Epigenetic Reprogramming by Shortening G1 Phase.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  10. Article
  11. Article
  12. Biomolecular condensates in immune cell fate.Nature reviews. Immunology · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Transcription regulation by biomolecular condensates.Nature reviews. Molecular cell biology · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Built to be imperfect.Nature cell biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Julian Naderi *Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Alexandre P Magalhaes *Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-4097-338X
Gözde KibarDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Gregoire StikCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0002-1404-1992
Yaotian ZhangDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Sebastian D MackowiakDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0003-1673-5389
Hannah M WielerDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Francesca RossiDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-1696-7078
Rene BuschowMicroscopy Core Facility, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-9800-2578
Marie Christou-KentCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Marc Alcoverro-BertranCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Thomas GrafCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0003-2774-4117
Martin VingronDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-1765-4241
Denes HniszDepartment of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany. hnisz@molgen.mpg.de.ORCID 0000-0002-6256-1693

Funding

Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (Federal Ministry for Education, Science, Research and Technology) FKZ 031L0169AConsell Català de Recerca i Innovació (Catalan Council for Research and Innovation) XXXDeutsche Forschungsgemeinschaft (German Research Foundation) HN 4/3-1
6 · The paper itself

Abstract

Transcription factors (TFs) control specificity and activity of gene transcription, but whether a relationship between these two features exists is unclear. Here we provide evidence for an evolutionary trade-off between the activity and specificity in human TFs encoded as submaximal dispersion of aromatic residues in their intrinsically disordered protein regions. We identified approximately 500 human TFs that encode short periodic blocks of aromatic residues in their intrinsically disordered regions, resembling imperfect prion-like sequences. Mutation of periodic aromatic residues reduced transcriptional activity, whereas increasing the aromatic dispersion of multiple human TFs enhanced transcriptional activity and reprogramming efficiency, promoted liquid-liquid phase separation in vitro and more promiscuous DNA binding in cells. Together with recent work on enhancer elements, these results suggest an important evolutionary role of suboptimal features in transcriptional control. We propose that rational engineering of amino acid features that alter phase separation may be a strategy to optimize TF-dependent processes, including cellular reprogramming.

Indexed as

Transcription FactorsCellular ReprogrammingDNAGene Expression RegulationHEK293 CellsHumansIntrinsically Disordered ProteinsMutationProtein BindingTranscription, GeneticDNAIntrinsically Disordered ProteinsTranscription Factors

Identifiers

PMID38969762
PMCPMC11321997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.